Radium-223 Dichloride in Peritoneal Dialysate Following Treatment of Metastatic Castration-resistant Prostate Cancer.
Sign Up to like & getrecommendations! Published in 2022 at "Health physics"
DOI: 10.1097/hp.0000000000001518
Abstract: ABSTRACT Radium-223 dichloride was administrated to a patient with castration-resistant metastatic prostate cancer (mCRPC) undergoing in-home peritoneal dialysis. The peritoneal dialysate and tubing sets were collected following four treatment cycles and analyzed for removable contamination,… read more here.
Keywords: prostate cancer; peritoneal dialysate; castration resistant; radium 223 ... See more keywords
ASO Author Reflections: Should We Be Using Dextrose-Containing Carrier Solutions for Perfusion During HIPEC?
Sign Up to like & getrecommendations! Published in 2018 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-018-6794-x
Abstract: Studies of hyperthermic intraperitoneal chemotherapy (HIPEC) have used peritoneal dialysate as a carrier solution for chemotherapy, likely because its use within the peritoneum is familiar to clinicians. Peritoneal dialysate, however, contains dextrose to create an… read more here.
Keywords: carrier solution; aso author; carrier; peritoneal dialysate ... See more keywords